Categories: Wire Stories

Nagoya Anesthesia Clinic Initiates Inbound Medical Treatment for Treatment-Resistant Depression and Intractable Chronic Pain Using Ketamine

NAGOYA, Japan–(BUSINESS WIRE)–Nagoya Anesthesia Clinic (https://nagoyamasui.com/), located in Nagoya City, Aichi Prefecture, Japan, has commenced inbound medical treatment for treatment-resistant depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and intractable chronic pain, utilizing the groundbreaking drug, Ketamine, starting in October 2023. In addition, the clinic offers other innovative procedures such as Echo-Guided Botox treatment for stiff neck and EchoGuided PRP therapy for tennis elbow.

Ketamine, a widely used general anesthetic dating back to over 50 years ago, has also been employed in the United States for the treatment of mental disorders and chronic pain for the past decade. Unlike conventional medications, which can take time to alleviate symptoms, Ketamine offers rapid symptom relief within hours to up to three weeks of administration. Moreover, it is associated with minimal long-term side effects, making it a promising treatment modality.

Nagoya Anesthesia Clinic, with its rich experience of performing over 1000 Ketamine infusions for various pain and mental disorders, has launched the Ketamine Clinic based on Ketamine’s potent analgesic and antidepressant properties. Ketamine infusions are typically administered in sets of 3 to 6 sessions over a span of 1 to 3 weeks, followed by a maintenance therapy once a month, a regimen notable for its low incidence of long-term side effects.

Nagoya Anesthesia Clinic is proud to be the first and only Ketamine Clinic in Japan and will begin accepting patients for inbound medical treatment of treatment-resistant depression, OCD, PTSD, and intractable chronic pain from October 2023. Building upon their Ketamine infusion experience dating back to 2010, they aim to support individuals struggling with treatment-resistant conditions through innovative, evidence-based, and compassionate approaches.

Nagoya Anesthesia Clinic “Ketamine Clinic” Information Page:

https://nagoyamasui.com/ketamine3

“Stiff Neck Botox” Information Page:

https://nagoyamasui.com/botox3

“Tennis Elbow PRP Therapy” Information Page:

https://nagoyamasui.com/prp3

Contacts

For inquiries, please contact:

JTB Medical & Healthcare:

jmhc_info@j-medical-healthcare.com

Alex

Recent Posts

Hafnia’s Q1 2024 Financial Results Presentation to Be Held on 15 May 2024

SINGAPORE--(BUSINESS WIRE)--Hafnia Limited (“Hafnia”, the “Company”, OSE ticker code: “HAFNI”, NYSE ticker code “HAFN”) will…

1 hour ago

Google Cloud and OCIC Group Support the Growth of Cambodia’s Tech Community

PHNOM PENH, Cambodia--(BUSINESS WIRE)--Google Cloud and the Overseas Cambodian Investment Corporation (“OCIC”) joined forces to…

1 hour ago

Sukhdeep Singh Joins SolarWinds as Head of Channel Sales APJ

SYDNEY, AUSTRALIA - Media OutReach Newswire - 10 May 2024 - SolarWinds (NYSE:SWI), a leading…

1 hour ago

ZF Aftermarket Champions Tailored Southeast Asia Solutions at the Malaysia Commercial Vehicle Expo (MCVE) 2024.

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 10 May 2024 - ZF Aftermarket, renowned…

3 hours ago

DFI Retail Group and PolyU SPEED Sign Memorandum of Understanding to Introduce Hong Kong’s FIRST QF Level 6 Programme in Retail

HONG KONG SAR - Media OutReach Newswire - 10 May 2024 - DFI Retail Group…

4 hours ago